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1. Introduction and Brazil use RDS as part of their national public healthHidden or hard-to-reach population subgroups are often
key to the maintenance of infectious diseases in human
populations [1]. However, it is often difficult to investigate
the factors that drive transmission in these groups by using
commonly used epidemiologic methods of data collection
because of the lack of an adequate sampling frame [2].
Researchers have therefore typically resorted to various
types of convenience sampling to gather data on hidden
populations [3]. Although convenience sampling has its
advantages, this approach is unable to generate unbiased
population-based estimates of infection prevalence and risk
factors. In an attempt to address these limitations,
respondent-driven sampling (RDS), a variant of a link-
tracing design, was proposed in 1997 [4].
RDS studies are characterized by both a specific data
collection method and specific statistical analysis methods.
Key features of the data collection include: (1) a small pro-
portion of the sample is recruited by the researcher (i.e., the
‘‘seeds’’) and a large proportion of the sample is recruited
(in recruitment ‘‘waves’’) by other members of the target
population to whom they have a social relationship; (2)
recording of recruitment connections between respondents
(e.g., who recruited whom); (3) the maximum number of
people that each participant can recruit is determined by
the researcher by giving out a limited number of recruitment
‘‘coupons’’; (4) respondents are compensated for partici-
pating in the study and recruiting others into the study.
Collectively, these features often make RDS an efficient data
collection method [5]. Although often efficient, the RDS
data collection method produces multiple challenges for
the analysis. First, because most of the sampling is conduct-
ed by respondents, assumptions about the sampling process
are needed. Second, under a variety of assumptions, not all
members of the target population will have the same proba-
bility of selection, so this probability is typically estimated
using a combination of modeling assumptions and study
data. Finally, because sampling happens through pre-
existing relationships, the observations are not independent.
These challenges make point and variance estimation from
RDS data more complex than from other forms of sampling.
Numerous approaches have been developed, and more are
currently under development [6e12].
Since its introduction in 1997 [4], there has been a rapid
increase in the number of surveys of hidden or hard-to-reach
populations using the RDS methodology, primarily of indi-
viduals at risk of sexually or parenterally transmitted infec-
tions including HIV [5,13], but also on topics as diverse
interpersonal violence [13] and strategies for improving can-
cer screening recruitment [14]. Many countries including
the United States, Ukraine, Vietnam, Mauritius, Morocco,systems, and data from RDS studies are used by major pub-
lic health organizations including the US Centers for Dis-
ease Control and Prevention, the Joint United Nations
Programme on HIV/AIDSs, and the Global Fund to Fight
AIDS, Tuberculosis and Malaria. The National Institutes
of Health alone has awarded around $100 million in funding
to projects using RDS and its variants [15].
Making sense of the rapidly increasing amount of data
collected using RDS [5,16] is crucial to the integration of
this information into the practice of medicine and public
health. However, the assessment of the strengths and weak-
nesses of RDS data and methods has been limited by the
inadequate reporting of RDS studies. An assessment of
22 randomly selected RDS studies has recently been carried
out [17]. The assessment found that overall only around
one-third of items sought were reported. Key details of
the sampling and statistical methods were particularly
poorly reported, including the methods of seed selection
(reported in 45% of studies), the number of recruits from
each seed and number of recruits in each recruitment wave
(33%), the details of the recruitment venues (33%), eligi-
bility criteria for seeds (!20%), wording of network size
questions (!20%), if seeds were included in the analysis
(!20%), how participants were trained to recruit others
(0%), and an explanation for differences between unad-
justed and adjusted estimates (0%) [17].
To improve the quality of reporting of observational
epidemiologic studies, the Strengthening the Reporting of
Observational studies in Epidemiology (STROBE) state-
ment [18e21] and extensions [22,23] were developed.
However, the STROBE statement is inadequate for report-
ing RDS studies because of the major differences in the
RDS sampling and estimation procedures. Our aims are
to present a systematic review of the number of RDS
studies and present the ‘‘STROBE-RDS’’ statement, a
checklist of essential items to present in RDS publications,
justified and supported by a stand-alone explanation and
elaboration document.2. Methods
2.1. Systematic literature review of RDS studies
A systematic literature review was carried out purely to
assess the number of published RDS studies and summarize
their geographical distribution.Briefly,we searched theMED-
LINE (1970e2013), EMBASE (1974e2013), and Global
Health (1910e2013) databases and asked experts for their col-
lections of relevant articles. Studies conducted in any country,
in any language, among any study population were included;
reviews, editorials, commentaries, and methodological
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Key findings
 Strengthening the Reporting of Observational
Studies in Epidemiology for respondent-driven
sampling studies (STROBE-RDS) was developed
based on STROBE statement following published
Guidance for Developers of Health Research Re-
porting Guidelines. The STROBE-RDS checklist
includes modifications to 12 of the 22 items on
the STROBE checklist. The two key areas that
required modification concerned the selection of
participants and the statistical analysis of the
sample.
What this adds to what was known?
 Respondent-driven sampling (RDS) is a new data
collection methodology used to estimate character-
istics of hard-to-reach groups, such as the HIV
prevalence in drug users. Many national public
health systems and international organizations rely
on RDS data. RDS reporting quality and available
reporting guidelines are inadequate. STROBE-
RDS is a checklist of essential items to present in
RDS publications.
What is the implication and what should change
now?
 The STROBE-RDS statement seeks to enhance the
transparency and utility of research using RDS. If
widely adopted, the STROBE-RDS checklist
should improve public health decision making in
infectious diseases.
R.G. White et al. / Journal of Cliniarticles were excluded. A previous assessment had identi-
fied the inadequacy of previous RDS reporting [17], and
therefore, further details on RDS reporting were not
collected. Full details are shown in the Supplementary
Material (Document 1 at www.jclinepi.com).
2.2. Statement development
The STROBE-RDS statement was developed after the
Guidance on Health Research Guidelines of Moher et al
[24]. The initial need for the RDS reporting guidelines was
identified in RDS expert and stakeholder discussions at an
RDS symposium in 2011 [25]. This was followed by a system-
atic evaluation of the reporting of RDS studies that concluded
that the reportingofRDSstudieswas inadequate [17]. Existing
guidelines were then reviewed, and the most suitable was the
STROBE statement [18,19], but this was assessed to be inad-
equate for reporting RDS studies because of the major differ-
ences in the RDS sampling and estimation procedures. Thevast majority of existing RDS studies use a cross-sectional
study design. Therefore, this statement is an extension of the
STROBE guidelines [18], the STROBE explanation and elab-
oration document [19], and the STROBE checklist for cross-
sectional studies [20]. Version 1 of the STROBE-RDS check-
list was distributed for consultation by posting on the Equator
Network Web site [26] and the RDS listserv [27] and by
sending to known experts. Themes emerging from the feed-
back included: strong support for the initiative and a request
to restrict the scope of the guidelines to cross-sectional epide-
miologic studies that seek to generate representative estimates
for the target population. The checklist was revised based on
this feedback, and version 2 was published in early October
2012 [28]. Version 2 of the checklist was piloted during
October 2012 by using it to guide manuscript drafting and
was sent to the STROBEgroup for feedback [18]. Researchers
(n5 5) piloting the checklist provided much useful feedback
and requested a stand-alone checklist and supporting docu-
ment. This and other feedback was used to develop version 3
of the checklist, which was discussed at a 2-day face-to-face
meeting in NewOrleans in October 2012 [29]. A list of poten-
tial meeting invitees was drawn up by a subset of coauthors
(R.G.W., A.J.H., and W.H.) after consultation with STROBE
initiative members, statisticians, epidemiologists, and empir-
ical RDS researchers. Potential invitees were categorized into
three groups: statisticians/surveymethodologists, epidemiolo-
gists/empirical RDS researchers, and journal editors. Fifty
percent (2 of 4), 46% (6 of 13), and 0% (0 of 2), respectively,
of meeting invitees in these three groups participated (11
meeting attendees in total). Participants were sent the draft
checklist, a summary of the previous RDS reporting [17]
and the guidelines by Moher et al. [24]. At the meeting, each
draft checklist item was presented and discussed in turn and
edited on screen in real time until agreement on the final
version of the checklist was reached by consensus and is pre-
sented in this manuscript. Consensus was defined as asking
verbally all participants if they agreed to the written text for
each item. There were no items on which consensus was not
reached during the meeting. After the face-to-face meeting,
this summary manuscript was drafted by the authors, and to
accompany the checklist, an ‘‘Explanation and Elaboration’’
document was developed and revised based on feedback from
experts and the STROBE group and is presented in the
Supplementary Material (Document 2 at www.jclinepi.com).2.3. Statement scope
The scope of the ‘‘STROBE-RDS’’ statement is limited
to (1) epidemiologic studies (the scope of the original
STROBE guidelines), (2) cross-sectional studies (the most
common RDS study design to date), and (3) RDS studies
that seek to generate representative estimates for the target
population (currently the most contentious and potentially
most policy-relevant use of RDS). Furthermore, as RDS
is both a sampling and a data analysis method, guidelines
for reporting on both aspects of RDS are provided. Finally,
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STROBE-RDS checklist, we aim to provide a self-
contained statement that minimizes the need to refer to
other documents when reporting on an RDS study.3. Results
The systematic literature review and input from ex-
perts identified that globally over 460 peer-reviewed pub-
lications have reported using RDS since the mid-1990s,
with most published since 2006 (Fig. 1A). Fig. 1B shows
the global distribution of study locations. RDS studies
have been conducted in 69 countries, including the
United States of America (151 studies), China (70), India
(32), Mexico (22), and South Africa (16). The articles
came from 141 different journals. Most journals (91)
had published either one or two articles included in the
review. Nine journals had published 10 or more articles
(or conference abstracts). Supplementary Material
(Document 1 at www.jclinepi.com) provides more details
of review methods, results, and included and excluded
articles.
In Table 1, we present the proposed STROBE-RDS
statement checklist, a modification of the STROBE state-
ment checklist for cross-sectional studies [20]. The left col-
umn lists the original STROBE checklist for cross-sectional
studies. The right column summarizes the reporting recom-
mendation. A three-column version of the checklist, high-
lighting the changes from the original STROBE checklist,
is shown in the supplementary information, along with an
explanation and elaboration document [Supplementary
Material (Document 2 at www.jclinepi.com)]. As there is
considerable variation in the use of terms and definitions
across the disciplines in which RDS is used, we also present
a list of suggested RDS terms and definitions to be used
when reporting RDS studies (Box 1).
The STROBE-RDS checklist provides modifications to
12 of the 22 items on the STROBE checklist. The two
key areas requiring modification concerned the selectionFig. 1. (A) Number of published peer-reviewed studies using respondent-driv
number of published peer-reviewed studies using respondent-driven sampliof participants and the statistical analysis of the sample.
These modifications are summarized below.
3.1. Selection of participants
As members of the target population, not researchers,
recruit most study participants in RDS studies, details of
the formative research conducted before the study (T5b)
and of how participants were trained to recruit others (6a)
should be reported. Key details of the recruitment process
should also be reported, including the number of coupons is-
sued per person, any time limits for referral (6a), procedures
of seed selection (6b), the exact wording of personal network
size question(s) (6d), the incentives for participation and
recruitment (6e), and how the recruitererecruit relationship
was tracked (7b). Variation in study procedures during data
collection should also be reported (6c). Methods to assess
eligibility and reduce repeat enrollment should be described
(8b) so that other researchers can understand the data collec-
tion process and any biases it might introduce. Authors
should report reasons for nonparticipation at each stage
(e.g., not eligible, does not consent, decline to recruit others)
(13b), the number of coupons issued and returned (13d), the
number of recruits by seed and number of recruitment waves
for each seed (13e), any recruitment challenges (e.g., com-
mercial exchange of coupons, imposters, duplicate recruits),
and how they were addressed (13f) (Table 1, items 5b,
6a,b,c,d,e, 7b, 8b, 13b,d,e,f).
3.2. Statistical analysis
Several different estimators exist for estimating the
prevalence of a specific trait (e.g., HIV prevalence) from
RDS data [6e12]. There are also a number of different
methods for producing confidence intervals around these
estimates [8,30e32]. Evaluations of these methods have
been equivocal [33e35], and the best estimator may
depend on specific features of a study [36]. At this time,
there is no consensus that one estimator should be univer-
sally used. As such, we recommend authors clearlyen sampling 1990eJuly 2013. * 5 part year. (B) World map showing
ng 1990eJuly 2013, by country.
Table 1. STROBE-RDS Statement Checklist
Item # Original STROBE checklist for cross-sectional studies STROBE-RDS checklist
Title and abstract 1 (a) Indicate the study’s design with a commonly used term
in the title or the abstract
(a) Indicate ‘‘respondent-driven sampling’’ in the title or
abstract
(b) Provide in the abstract an informative and balanced
summary of what was done and what was found
(b) Provide in the abstract an informative and balanced
summary of what was done and what was found
Introduction
Background/
rationale
2 Explain the scientific background and rationale for the
investigation being reported
Explain the scientific background and rationale for the
investigation being reported
Objectives 3 State specific objectives, including any prespecified
hypotheses
State-specific objectives, including any prespecified
hypotheses
Methods
Study design 4 (a) Present key elements of study design early in the
article
(a) Present key elements of study design early in the
article
(b) State why RDS was chosen as the sampling method
Setting 5 (a) Describe the setting, locations, and relevant dates,
including periods of recruitment, exposure, follow-up,
and data collection
(a) Describe the setting, locations, and relevant dates,
including periods of recruitment and data collection
(b) Describe formative research findings used to inform
RDS study
Participants 6 (a) Give the eligibility criteria and the sources and
methods of selection of participants
(a) Give the eligibility criteria and the sources and
methods of selection of participants. Describe how
participants were trained/instructed to recruit others,
number of coupons issued per person, any time limits
for referral
(b) Describe methods of seed selection and state number
at start of study and number added later
(c) State if there was any variation in study procedures
during data collection (e.g., changing numbers of
coupons per recruiter, interruptions in sampling, or
stopping recruitment chains)
(d) Report wording of personal network size question(s)
(e) Describe incentives for participation and recruitment
Variables 7 (a) Clearly define all outcomes, exposures, predictors,
potential confounders, and effect modifiers. Give
diagnostic criteria, if applicable
(a) If applicable, clearly define all outcomes, correlates,
predictors, potential confounders, effect modifiers, and
diagnostic criteria
(b) State how recruitererecruit relationship was tracked
Data sources/
measurement
8 (a) For each variable of interest, give sources of data and
details of methods of assessment (measurement).
Describe comparability of assessment methods if there
is more than one group
(a) For each variable of interest, give sources of data and
details of methods of measurement. Describe
comparability of measurement methods if there is more
than one group
(b) Describe methods to assess eligibility and reduce
repeat enrollment (e.g., coupon manager software,
biometrics)
Bias 9 Describe any efforts to address potential sources of bias Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at Explain how the study size was arrived at
Quantitative
variables
11 Explain how quantitative variables were handled in the
analyses. If applicable, describe which groupings were
chosen and why
Explain how quantitative variables were handled in the
analyses. If applicable, describe which groupings were
chosen and why
Statistical
methods
12 (a) Describe all statistical methods, including those used
to control for confounding
(a) Describe all statistical methods, including those to
account for sampling strategy (e.g., the estimator used)
and, if applicable, those used to control for confounding
(b) State data analysis software, version number, and
specific analysis settings used
(b) Describe any methods used to examine subgroups and
interactions
(c) Describe any methods used to examine subgroups and
interactions
(c) Explain how missing data were addressed (d) Explain how missing data were addressed
(d) If applicable, describe analytical methods taking
account of sampling strategy
(e) Describe any sensitivity analyses (e) Describe any sensitivity analyses
(f) Report any criteria used to support statements on
whether estimator conditions or assumptions were
appropriate
(g) Explain how seeds were handled in analysis
(Continued )
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Table 1. Continued
Item # Original STROBE checklist for cross-sectional studies STROBE-RDS checklist
Results
Participants 13 (a) Report the numbers of individuals at each stage of the
studydfor example, numbers potentially eligible,
examined for eligibility, confirmed eligible, included in
the study, completing follow-up, and analyzed
(a) Report the numbers of individuals at each stage of the
studydfor example, numbers potentially eligible,
examined for eligibility, confirmed eligible, included in
the study, and analyzed
(b) Give reasons for nonparticipation at each stage (b) Give reasons for nonparticipation at each stage (e.g.,
not eligible, does not consent, decline to recruit others)
(c) Consider use of a flow diagram (c) Consider use of a flow diagram
(d) Report number of coupons issued and returned
(e) Report number of recruits by seed and number of RDS
recruitment waves for each seed. Consider showing
graph of entire recruitment network
(f) Report recruitment challenges (e.g., commercial
exchange of coupons, imposters, duplicate recruits) and
how addressed
(g) Consider reporting estimated design effect for
outcomes of interest
Descriptive data 14 (a) Give characteristics of study participants (e.g.,
demographic, clinical, social) and information on
exposures and potential confounders
(a) Give characteristics of study participants (e.g.,
demographic, clinical, social) and, if applicable,
information on correlates and potential confounders.
Report unweighted sample size and percentages,
estimated population proportions or means with
estimated precision (e.g., 95% confidence interval)
(b) Indicate the number of participants with missing data
for each variable of interest
(b) Indicate the number of participants with missing data
for each variable of interest
Outcome data 15 Report numbers of outcome events or summary measures If applicable, report number of outcome events or
summary measures
Main results 16 (a) Give unadjusted estimates and, if applicable,
confounder-adjusted estimates and their precision (e.g.,
95% confidence intervals). Make clear which
confounders were adjusted for and why they were
included
(a) Give unadjusted and study designeadjusted estimates
and, if applicable, confounder-adjusted estimates and
their precision (e.g., 95% confidence intervals). Make
clear which confounders were adjusted for and why they
were included
(b) Report category boundaries when continuous variables
were categorized
(b) Report category boundaries when continuous variables
were categorized
(c) If relevant, consider translating estimates of relative
risk into absolute risk for a meaningful period
(c) If adjustment of primary outcome leads to marked
changes, report information on factors influencing the
adjustments (e.g., personal network sizes, recruitment
patterns by group, key confounders)
Other analyses 17 Report other analyses donedfor example, analyses of
subgroups and interactions and sensitivity analyses
Report other analyses donedfor example, analyses of
subgroups and interactions, sensitivity analyses,
different RDS estimators and definitions of personal
network size
Discussion
Key results 18 Summarize key results with reference to study objectives Summarize key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account
sources of potential bias or imprecision. Discuss both
direction and magnitude of any potential bias
Discuss limitations of the study, taking into account
sources of potential bias or imprecision. Discuss both
direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results
considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other
relevant evidence
Give a cautious overall interpretation of results
considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other
relevant evidence
Generalizability 21 Discuss the generalizability (external validity) of the study
results
Discuss the generalizability (external validity) of the study
results
Other information
Funding 22 Give the source of funding and the role of the funders for
the present study and, if applicable, for the original
study on which the present article is based
Give the source of funding and the role of the funders for
the present study and, if applicable, for the original
study on which the present article is based
Abbreviations: STROBE-RDS, Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling;
#, number.
Italics highlight changes from STROBE statement checklist for cross-sectional studies [20]. Full details of modifications from [20] are shown in
Table S1 in Supplementary Material at www.jclinepi.com.
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Box 1 Respondent-driven sampling key terms and definitions
Candidate participantda coupon recipient who attempts to enroll in the study.
Coupondan invitation to enroll in the RDS study that a participant can give to other people.
Coupon recipientda person who receives a coupon.
Equilibriumdthis term has inconsistent usage in the RDS community. The most common usage is that the observed
sample composition matches the expected long-run sample composition assuming a specific model of the sampling
process.
Follow-up interviewdan interview where additional information is collected from the subset of participants who
return to the study site a second time to collect recruitment incentives and/or biological test results.
Homophilydthis term has inconsistent usage in the RDS community. Sometimes it is used to refer to the tendency
for sample recruitments to occur between participants in the same social category and sometimes to refer to the
tendency for relationships in the target population to occur between participants in the same social category.
Main interviewdinterview that is conducted of all participants where the main study information is collected.
Participantsdmembers of the target population who have provided consent and completed the main interview.
Participation incentivedthe money, goods, and/or services provided to participants for completing the main
interview.
Peer-recruited participantda participant recruited by a member of the target population.
Personal network size (also called ‘‘degree’’)dthe number of relationships a person has to members of the target
population.
Population estimatedan estimate of a characteristic of the study population that takes into account the RDS
sampling design.
Recruitment incentivedthe money, goods, and/or services provided to participants for each new participant they
are able to recruit.
Recruitment tree (also chain)dthe set of all participants linked to a specific seed.
Sample descriptionda summary statistic of participants that does not take into account the RDS sampling design.
Screening interviewda short initial interview with people hoping to enroll in the study that seeks to verify mem-
bership in the target population and request consent.
Seedda participant who is recruited by a researcher.
Target populationdthe set of people about whom the researchers wish to make estimates.
Wavedthe set of participants a given number of recruitments from a seed.
Abbreviation: RDS, respondent-driven sampling.
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adjust for sample design, both when making estimates
(Table 1, 12a,b) and when quantifying the uncertainty in
those estimates (16a,c). As the utility of the various
RDS estimators is unknown, we recommend reporting un-
adjusted and study designeadjusted estimates and, if
applicable, confounder-adjusted estimates and their preci-
sion (16a). If adjustment of the primary outcome leads to
marked changes, information on factors causing the
changes (e.g., personal network sizes, recruitment patterns
by group, key confounders) should be reported (16c)
(Table 1, items 12a,b, 16a,c).4. Discussion
The STROBE-RDS statement is a checklist of essential
items that should be reported in RDS studies. The statement
has several strengths. It is based on existing guidance for
reporting observational studies, [18e20] was developed
by an interdisciplinary group that included epidemiologists,
statisticians, and empirical RDS researchers, and explicitly
justifies changes from the original STROBE statement.The decisions made for the conduct and data analysis of
RDS studies will influence the representativeness of a
study’s results. The empirical evidence on how representa-
tive the study results are is limited, and improving the
methodology is an active research area. Transparent report-
ing is essential for developing a better evidence base and
improving RDS methods.
Based on feedback we received from researchers
writing up RDS studies during the piloting of earlier ver-
sions of this checklist [28], we decided to provide a
stand-alone STROBE-RDS checklist with full supporting
documentation, rather than only providing a modified
STROBE checklist. This should mean that researchers
writing up RDS studies will be more likely to use these
reporting guidelines. We encourage readers to read the
accompanying explanation and elaboration document in
full (supporting material) before embarking on writing
up an RDS study.
The statement can be used by authors, peer reviewers,
and editors to improve the reporting of RDS studies. We
invite journals to endorse STROBE-RDS, and although
STROBE-RDS will be published in English only once,
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commentaries, editorials, or use other means to raise the
awareness of the STROBE-RDS publication. The ability
to provide information in Web supplements should alleviate
concerns about the increased length of manuscripts result-
ing from following the guidelines. We welcome comments
directed to the corresponding author or via the journal or
Equator Network Web sites where the guidelines are also
deposited [26]. These will be used to update this
STROBE-RDS statement as RDS methods develop.
The STROBE-RDS statement does not prescribe or
dictate how an RDS study should be designed or analyzed.
Rather, it seeks to enhance the transparency of research
using RDS to increase the understanding of individual
studies and enable comparisons between studies. If widely
adopted, the STROBE-RDS checklist should improve
global public health decision making for infectious dis-
eases. Further studies could assess the impact of
STROBE-RDS on the transparency of RDS research and
on global public health decision making.
4.1. Search strategy and selection criteria
We searched published (physically published or online),
peer-reviewed literature accessible through July 2013 that
reported using RDS. Studies from all countries were
included. We conducted searches using MEDLINE
(1970e2013), EMBASE (1974e2013), and Global Health
(1910e2013). Search terms used included ‘‘respondent
driven’’ or ‘‘respondent-driven’’ or ‘‘RDS.’’Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.jclinepi.2015.04.002.References
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